Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration

References

• Betbeder D, Spérandio S, Latapie JP, de Nadai J, Etienne A, Zajac JM, Francés B. (2000). Biovector nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm Res, 17, 743–748.
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Pokharkar VB. (2006). Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech, 7, E50.
   PubMed Web of Science ®Google Scholar
• Dawbarn D, Allen SJ. (2003). Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol, 29, 211–230.
   PubMed Web of Science ®Google Scholar
• Fernández-Urrusuno R, Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. (1999). Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res, 16, 1576–1581.
   PubMed Web of Science ®Google Scholar
• Illum L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol, 56, 3–17.
   PubMed Web of Science ®Google Scholar
• Illum L, Farraj NF, Davis SS. (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res, 11, 1186–1189.
   PubMed Web of Science ®Google Scholar
• Janes KA, Calvo P, Alonso MJ. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev, 47, 83–97.
   PubMed Web of Science ®Google Scholar
• Komatsu H, Kitajima A, Okada S. (1995). Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull, 43, 1412–1415.
   PubMed Web of Science ®Google Scholar
• Kosaka K, Yokoi T. (2003). Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol Pharm Bull, 26, 1620–1622.
   PubMed Web of Science ®Google Scholar
• Kravtzoff R, Fisher A, De Miguel I, Perkins A, Major M, Betbeder D, Etienne A. (1998). Nasal residence time evaluation of cationic Biovector™ in human volunteers. Proc Int Symp Control Rel Bioact Mater, 25, 818–819.
   Google Scholar
• Martínez HJ, Dreyfus CF, Jonakait GM, Black IB. (1985). Nerve growth factor promotes cholinergic development in brain striatal cultures. Proc Natl Acad Sci USA, 82, 7777–7781.
   PubMed Web of Science ®Google Scholar
• Nagamoto T, Hattori Y, Takayama K, Maitani Y. (2004). Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res, 21, 671–674.
   PubMed Web of Science ®Google Scholar
• Nanjwade B, Parikh K, Deshmukh R, Nanjwade V, Gaikwad K. (2011). Development and evaluation of intranasal mucoadhesive microspheres of neostigmine bromide. Pharm Anal Acta, 2, 2.
   Google Scholar
• Park JA, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, Chun HS. (2008). Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport, 19, 1301–1304.
   PubMed Web of Science ®Google Scholar
• Satoh T, Kosaka K, Itoh K, Kobayashi A, Yamamoto M, Shimojo Y, Kitajima C, Cui J, Kamins J, Okamoto S, Izumi M, Shirasawa T, Lipton SA. (2008). Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem, 104, 1116–1131.
   PubMed Web of Science ®Google Scholar
• Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, Mills KH, Nicholson KG. (2006). Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J Virol, 80, 4962–4970.
   PubMed Web of Science ®Google Scholar
• Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. (2008). New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev, 59, 201–220.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Frey WH 2nd. (2001). Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet, 40, 907–946.
   PubMed Web of Science ®Google Scholar
• Vaka SRK, Murthy SN, Repka MA, Nagy T. (2011). Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci, 100, 3139–3145.
   PubMed Web of Science ®Google Scholar
• Vaka SRK, Sammeta SM, Day LB, Murthy SN. (2009). Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci, 98, 3640–3646.
   PubMed Web of Science ®Google Scholar
• Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ. (2004). Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm, 57, 123–131.
   PubMed Web of Science ®Google Scholar
• Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. (2002). Design of biodegradable particles for protein delivery. J Control Release, 78, 15–24.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. (2008). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm, 70, 735–740.
   PubMed Web of Science ®Google Scholar
• Yan H, Wang L, Li X, Yu C, Zhang K, Jiang Y, Wu L, Lu W, Tu P. (2009). High-performance liquid chromatography method for determination of carnosic acid in rat plasma and its application to pharmacokinetic study. Biomed Chromatogr, 23, 776–781.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu Y, Yang W, Wang C, Fu S, Shen X. (2006). Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci, 95, 181–191.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Yang W, Wang C, Hu J, Fu S, Dong L, Wu L, Shen X. (2007). Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm, 67, 621–631.
   PubMed Web of Science ®Google Scholar